
Adverse Effects of Bisphosphonates: Implications for Osteoporosis Management
Keywords: BMD; bone mineral density; CTX; carboxy-terminal collagen crosslinks; FDA; Food and Drug Administration; FRAX; fracture risk assessment; GI; gastrointestinal; IV; intravenous; ONJ; osteonecrosis of the jaw;